We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MOMO:NASDAQHello Group Inc. Analysis

Data as of 2026-05-19 - not real-time

$6.05

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Hello Group Inc. (MOMO) trades around $6.05, just above its 20‑day SMA of $6.20 and marginally above the 50‑day SMA of $6.11, indicating a very tight short‑term price corridor. The RSI sits at 44.8, suggesting neutral momentum, while the MACD histogram is negative and the signal line is bearish, hinting at modest downside pressure. Volume has been decreasing, and the stock is hovering near its technical support at $6.02, with resistance near $6.49. On the fundamentals side, the forward P/E of 5.78 and current P/E of 8.64 are well below the industry average of 17.1, and the price‑to‑book of 0.57 underscores a deep discount to book value. The company’s free cash flow of $5.3 bn and a cash pile of $8.6 bn provide a solid liquidity cushion despite a modest debt load. Revenue has slipped 2.3% year‑over‑year, and operating margins sit at 11.9%, reflecting modest profitability. The 30‑day volatility of 31% and beta around 0.6 point to higher price swings than the broader market. Analyst consensus targets around $8.70 imply roughly 44% upside, while the DCF fair value estimate is dramatically higher, signaling potential mispricing. Recent filings of the FY 2025 Form 20‑F and the upcoming Q1 2026 earnings release on June 2 could move the stock sharply. The Chinese regulatory environment for social networking platforms remains a key headwind, adding uncertainty to the outlook. Overall, the stock appears undervalued but faces short‑term technical weakness and medium‑term regulatory risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • price near technical support
  • bearish MACD signal
  • decreasing trading volume

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • significant valuation discount to peers
  • ~44% upside implied by analyst targets
  • upcoming Q1 earnings catalyst

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • secular revenue decline
  • high regulatory and geographic risk in China
  • limited growth prospects despite low valuation

Key Metrics & Analysis

Financial Health

Revenue Growth-2.30%
Profit Margin7.75%
P/E Ratio8.6
ROE7.16%
ROA5.26%
Debt/Equity1.16
P/B Ratio0.6
Op. Cash Flow$1.2B
Free Cash Flow$5.3B
Industry P/E17.1

Technical Analysis

TrendNeutral
RSI44.8
Support$6.01
Resistance$6.49
MA 20$6.20
MA 50$6.11
MA 200$6.85
MACDBearish
VolumeDecreasing
Fear & Greed Index89.2

Valuation

Fair Value$522.37
Target Price$8.70
Upside/Downside43.88%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.77
Volatility31.40%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.